Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Provided By GlobeNewswire
Last update: Feb 24, 2025
HOLLISTON, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society of Toxicology (SOT) conference from March 17-20, 2025, in Orlando. Building upon its comprehensive product portfolio, these latest developments open promising new avenues for progressing preclinical research and organoid-based therapeutic development.
Read more at globenewswire.com0.3933
+0.03 (+7.99%)
Find more stocks in the Stock Screener
HBIO Latest News and Analysis
15 days ago - ChartmillTraders are paying attention to the gapping stocks in Tuesday's session.Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
